Anal Cancer Market Magnificent Possibilities, Growth with Detailed Industry Study, Detailed Analysis and Forecast
Cancer occurs when normal cells lose their
ability to control their growth or multiplication, causing them to invade
tissues and spread to other parts of the body. Anal cancer is a rare type of
cancer that occurs in the anal canal, a small tube at the end of your rectum
that allows stool to exit your body. Anal cancer, also known as squamous cell
carcinoma, develops from cells surrounding or in the anal opening or, in rare
cases, in the anal canal. This type of cancer is commonly associated with the
human papillomavirus (HPV), and HPV cancers or cervical cancers are at a high
risk of developing into anal cancer. Anal cancer has no specific symptoms, but
some may include bleeding from the anal area, a lump or swelling near the anus,
or a change in bowel habits.
Anal cancer forms malignant cells in the
tissues of the anus, whereas colorectal cancer begins in the colon or the
rectum. Colon cancer and rectal cancer are frequently lumped together because
they share many characteristics. Bowel cancer and anal cancer can affect both
men and women. Anal
Cancer Market, also known as bowel cancer, starts in the colon or
rectum. Depending on where they start, these tumors are also known as colon
cancer or rectal cancer. Colorectal cancer is the world's third most common
cancer and the fourth leading cause of cancer-related deaths.
According to the Anal Cancer Market
statistics, approximately 6000 cases of anal cancer are diagnosed each year in
the United States, and the number is slowly increasing. The aging population,
sexually transmitted diseases, multiple sexual partners, and smoking are the
major factors driving the Anal Cancer Market therapeutics. According to the
World Health Organization, 290 million women are infected with HPV, and the
risk is doubled due to unhealthy sex. Early diagnosis, which is only available
in developed or high-income countries and is accessible, is critical for
treating anal cancer.
Abbott Diagnostics, Alere, Taiwan Liposome
Company Ltd., Merck & Co., Quest Diagnostics, Roche Ltd., and Taiho
Pharmaceutical are among the leading players in the anal and colorectal cancer
market. The FDA approval has been hailed as a watershed moment in the market
for anal and colorectal cancer treatments.
Comments
Post a Comment